Sunshine BiopharmaSBFM
13F holders, Q2 2026 (June 30)9holders
$2.10avg. 13F price*
At the end of Q2 2026, 9 institutions reported holding Sunshine Biopharma Inc. (SBFM) in their 13F filings. The largest holders were Jane Street Group, LLC ($31K), Morgan Stanley ($808) and SBI Securities Co., Ltd. ($340).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781809
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $33K |
| Exits | 0 | $0 |
Ownership 9 holders
| Jane Street Group, LLC | 0.00% | New | 14,974 | $31K |
| Morgan Stanley | 0.00% | New | 385 | $808 |
| SBI Securities Co., Ltd. | 0.00% | New | 162 | $340 |
| National Bank of Canada | 0.00% | New | 5 | $10 |
| Osaic Holdings, Inc. | 0.00% | New | 2 | $4 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $2 |
| Farther Finance Advisors, LLC | 0.00% | New | 1 | $2 |
| TD Waterhouse Canada Inc. | 0.00% | New | 1 | $2 |
| Strive Financial Group ,LLC | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is SBFM's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.